3-({5-bromo-1H-pyrazolo[3,4-b]pyridin-1-yl}methyl)pyridine

Catalog No. :
ACRMDP053
CAS No. :
1016886-81-9
Molecular Formula :
C12H9BrN4
Molecular Weight :
289.14

IUPAC Name:5-bromo-1-(pyridin-3-ylmethyl)-1H-pyrazolo[3,4-b]pyridine

3-({5-bromo-1H-pyrazolo[3,4-b]pyridin-1-yl}methyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$273.00Login to see priceInquiryInquiry
100mg95%$398.00Login to see priceInquiryInquiry
250mg95%$562.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-({5-bromo-1H-pyrazolo[3,4-b]pyridin-1-yl}methyl)pyridine
IUPAC Name5-bromo-1-(pyridin-3-ylmethyl)-1H-pyrazolo[3,4-b]pyridine
MDL No.MFCD09938381
Molecular FormulaC12H9BrN4
Molecular Weight289.14
SMILESBrC1=CN=C(N(CC2=CC=CN=C2)N=C3)C3=C1
InChI KeyCNFWXPHWBASIAI-UHFFFAOYSA-N
Synonym3-({5-Bromo-1H-pyrazolo[3,4-b]pyridin-1-yl}methyl)pyridine;1H-Pyrazolo[3,4-b]pyridine, 5-bromo-1-(3-pyridinylmethyl)-
CAS No.1016886-81-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRMDP053 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBGJT793 route compound structure diagram
    ACBGJT7931449693-24-6 In Stock
  4. Then
  5. ACRMDP053 route product structure diagram
    ACRMDP0531016886-81-9
Inquiry

2. ACRMDP053 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBGJT793 route compound structure diagram
    ACBGJT7931449693-24-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRMDP053 route product structure diagram
    ACRMDP0531016886-81-9
Inquiry

Comments (0)